Merck, Qurient team up to evaluate Keytruda|Q901 combo for solid tumors
South Korea''s Qurient signed a clinical collaboration agreement with Merck (MRK) to study Q901 in combination with the Kenilworth, N.J.-based company''s blockbuster cancer drug…
Merck, Qurient team up to evaluate Keytruda|Q901 combo for solid tumors
South Korea''s Qurient signed a clinical collaboration agreement with Merck (MRK) to study Q901 in combination with the Kenilworth, N.J.-based company''s blockbuster cancer drug…